Patents by Inventor Gerard A. Rodrigues

Gerard A. Rodrigues has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Content protection for device rendering
    Patent number: 11757848
    Abstract: Users access content using a variety of formats, where some formats provide stronger encryption or protections than others. Content transmitted over open protocols may expose content to unauthorized third parties or enable unauthorized use of the content. The content may be protected by converting the content to a set of instructions on a user device, where the instructions correlate characters to identifications and outlines of the characters with instructions for rendering the characters. Different segments of content may have different mappings between characters, identifications, and outlines to add time or resource use to attempts to reverse engineer the instructions.
    Type: Grant
    Filed: June 23, 2021
    Date of Patent: September 12, 2023
    Assignee: Amazon Technologies, Inc.
    Inventors: Jan Zieh, Musachy Barroso, Lokesh Joshi, Mark David Van Hamersveld, Jeffrey Gerard Rodrigues, Mohammad A. Kanso, Manigandan Natarajan, Sriram Subramanian
  • Aromatic bycyclic derivatives as CXCR4 receptor modulators
    Patent number: 9090624
    Abstract: The present invention relates to novel aromatic bicyclic derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of the CXCR4 receptor.
    Type: Grant
    Filed: August 2, 2012
    Date of Patent: July 28, 2015
    Assignee: Allergan, Inc.
    Inventors: Vidyasagar Vuligonda, Richard L. Beard, Thong Vu, John E. Donello, Gerard Rodrigues, Veena Viswanath, Michael E. Garst
  • Treating ocular diseases using peroxisome proliferator—activated receptor delta antagonists
    Patent number: 8729042
    Abstract: The present invention provides novel agents, expression constructs, compositions and methods useful for treating an ocular disease associated with unwanted PPAR? activity through the modulation of PPAR? expression. The PPAR? interference RNA (iRNA) agents, expression constructs encoding such agents, and compositions comprising such agents or constructs are directed against RNA molecules encoding PPAR?. The methods comprise treating an ocular disease associated with unwanted PPAR? activity in a patient in need thereof by administering an effective amount of a pharmaceutical composition comprising a PPAR? iRNA agent or expression construct encoding such agent to the patient to reduce a symptom associated with unwanted PPAR? activity in the patient.
    Type: Grant
    Filed: October 25, 2011
    Date of Patent: May 20, 2014
    Assignee: Allergan, Inc.
    Inventors: Gerard A. Rodrigues, John E. Donello
  • AROMATIC BYCYCLIC DERIVATIVES AS CXCR4 RECEPTOR MODULATORS
    Publication number: 20130035347
    Abstract: The present invention relates to novel aromatic bicyclic derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of the CXCR4 receptor.
    Type: Application
    Filed: August 2, 2012
    Publication date: February 7, 2013
    Inventors: Vidyasagar Vuligonda, Richard L. Beard, Thong Vu, John E. Donello, Gerard Rodrigues, Veena Viswanath, Michael E. Garst
  • Bicyclic compounds having activity at the CXCR4 receptor
    Patent number: 8193203
    Abstract: A compound represented by the structural formula: Therapeutic methods, compositions, and medicaments related thereto are also disclosed.
    Type: Grant
    Filed: May 18, 2009
    Date of Patent: June 5, 2012
    Assignee: Allergan, Inc.
    Inventors: Richard L. Beard, Tien T. Duong, Thong H. Vu, Vidyasagar Vuligonda, John E. Donello, Michael E. Garst, Gerard A. Rodrigues
  • Treating Ocular Diseases Using Peroxisome Proliferator-Activated Receptor Delta Antagonists
    Publication number: 20120136041
    Abstract: The present invention provides novel agents, expression constructs, compositions and methods useful for treating an ocular disease associated with unwanted PPAR? activity through the modulation of PPAR? expression. The PPAR? interference RNA (iRNA) agents, expression constructs encoding such agents, and compositions comprising such agents or constructs are directed against RNA molecules encoding PPAR?. The methods comprise treating an ocular disease associated with unwanted PPAR? activity in a patient in need thereof by administering an effective amount of a pharmaceutical composition comprising a PPAR? iRNA agent or expression construct encoding such agent to the patient to reduce a symptom associated with unwanted PPAR? activity in the patient.
    Type: Application
    Filed: October 25, 2011
    Publication date: May 31, 2012
    Inventors: Gerard A. Rodrigues, John E. Donello
  • Compositions and Methods for the Treatment of Ophthalmic Disease
    Publication number: 20120003275
    Abstract: Compositions and methods of treating ocular disorders comprising CXCR4 inhibitory compositions.
    Type: Application
    Filed: June 10, 2011
    Publication date: January 5, 2012
    Inventors: Gerard A. Rodrigues, John E. Donello, Anne P. McLaughlin, Fabien J. Schweighoffer, Florence Mahé
  • Compositions and methods for the treatment of ophthalmic disease
    Patent number: 7964191
    Abstract: Compositions and methods of treating ocular disorders comprising CXCR4 inhibitory compositions.
    Type: Grant
    Filed: February 2, 2007
    Date of Patent: June 21, 2011
    Assignee: Allergan, Inc.
    Inventors: Gerard A. Rodrigues, John E. Donello, Anne P. McLaughlin, Fabien J. Schweighoffer, Florence Mahé
  • Treating Ocular Diseases Using Peroxisome Proliferator-Activated Receptor Delta Antagonists
    Publication number: 20100183696
    Abstract: The present invention provides novel agents, expression constructs, compositions and methods useful for treating an ocular disease associated with unwanted PPAR? activity through the modulation of PPAR? expression The PPAR? interference RNA (iRNA) agents, expression constructs encoding such agents, and compositions comprising such agents or constructs are directed against RNA molecules encoding PPAR? The methods comprise treating an ocular disease associated with unwanted PPAR? activity in a patient in need thereof by administering an effective amount of a pharmaceutical composition comprising a PPAR? iRNA agent or expression construct encoding such agent to the patient to reduce a symptom associated with unwanted PPAR? activity in the patient.
    Type: Application
    Filed: January 28, 2008
    Publication date: July 22, 2010
    Applicant: ALLERGAN, INC
    Inventors: Gerard A. Rodrigues, John E. Donello
  • BICYCLIC COMPOUNDS HAVING ACTIVITY AT THE CXCR4 RECEPTOR
    Publication number: 20090312305
    Abstract: A compound represented by the structural formula: Therapeutic methods, compositions, and medicaments related thereto are also disclosed.
    Type: Application
    Filed: May 18, 2009
    Publication date: December 17, 2009
    Applicant: ALLERGAN, INC.
    Inventors: Richard L. Beard, Tien T. Duong, Thong H. Vu, Vidyasagar Voligonda, John E. Donello, Michael E. Garst, Gerard A. Rodrigues
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF OPHTHALMIC DISEASE
    Publication number: 20070203089
    Abstract: Compositions and methods of treating ocular disorders comprising CXCR4 inhibitory compositions.
    Type: Application
    Filed: February 2, 2007
    Publication date: August 30, 2007
    Inventors: GERARD A. RODRIGUES, John E. Donello, Anne P. McLaughlin, Fabien J. Schweighoffer, Florence Mahe